Early Detection
Scientists at have developed a blood test that can detect cancerous tumours years before symptoms appear, potentially revolutionizing early diagnosis and treatment outcomes.
The test identifies genetic material shed by tumours in the bloodstream, with the ability to detect signs of cancer over three years in advance for some patients.
Study Findings and Future Implications
In a study involving 52 participants, the multicancer early detection (MCED) test flagged eight cancer cases, showcasing a 31% detection rate before formal diagnosis.
Researchers aim to validate these findings in larger trials, hoping to standardize blood tests for early cancer screening, which could significantly improve treatment outcomes and survival rates.